Import – Talk Bio

Navigating Trumps tariffs for pharma

2 days ago talkbio0Tagged Biomechanical compliance, Financial cost, HTS, Import, tariffs

Import, Biomechanical compliance, Financial cost, tariffs, HTS

U.S. Biotechs Reveal Tariff Exposure as Trade Inquiry Signals Imminent Pharmaceutical Tariffs

1 week ago talkbio0Tagged Evaluation, global supply chain, Impact food supplement, Import, Manufacturing, pharmaceutical ingredients, pharmaceutical tariffs, Policy, regulatory, reshoring, Sectioning technique, supply chain exposure, TNFRSF19 gene, United States

U.S. biotech, pharmaceutical tariffs, Section 232 investigation, supply chain exposure, trade policy, import costs, reshoring manufacturing, drug pricing, global supply chain, pharmaceutical ingredients, regulatory impact

Trump’s Tariffs Threaten to Disrupt Healthcare Supply Chain and Increase Costs

3 months ago talkbio0Tagged Drug Industry, Drug shortages, Health care facility, Import, Medical Devices, medical supply chain, Trump tariffs

Trump tariffs, medical supply chain, healthcare costs, drug shortages, medical devices, pharmaceutical industry, import taxes

FDA Imposes Import Restrictions on 11 Viatris Products from Indian Facility Due to Regulatory Violations

4 months ago talkbio0Tagged Facility (object), Import, pharmaceutical manufacturing, Regulatory Violations, restrictions, United States Food and Drug Administration, Viatris

Viatris, FDA, Import Restrictions, India Facility, Regulatory Violations, Pharmaceutical Manufacturing